BioCryst Pharmaceuticals, Inc. ( BCRX) - Key Metrics

BCRX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.86 $0.31 $0.41 $0.41
2026Q1 $0.65 -$2.98 -$0.26 -$0.26
2025Q4 $1.93 $1.17 $1.31 $1.30
2025Q3 $0.76 $0.06 $0.20 $0.19
2025Q2 $0.78 $0.02 $0.20 $0.20

BCRX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 8.06
2026Q1 0% -0.80
2025Q4 0% 1.67
2025Q3 0% 30.90
2025Q2 0% 112.00

BCRX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 4.13% 0%
2026Q1 -2.71% 0%
2025Q4 16.73% 0%
2025Q3 2.53% 0%
2025Q2 2.19% 0%

BCRX

Price: $8.02

52 week price:
6.00
11.22

Earnings Per Share: -1.47 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.7 million

Ebitda: -12.8 million

Market Capitalization: 2.0 billion

Links: